Suivre
Marilyn N. Martinez
Marilyn N. Martinez
Adresse e-mail validée de fda.hhs.gov
Titre
Citée par
Citée par
Année
A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals
MN Martinez, GL Amidon
The Journal of Clinical Pharmacology 42 (6), 620-643, 2002
7542002
Pharmacology of the fluoroquinolones: a perspective for the use in domestic animals
M Martinez, P McDermott, R Walker
The Veterinary Journal 172 (1), 10-28, 2006
5002006
Dosing regimen matters: the importance of early intervention and rapid attainment of the pharmacokinetic/pharmacodynamic target
MN Martinez, MG Papich, GL Drusano
Antimicrobial agents and chemotherapy 56 (6), 2795-2805, 2012
2302012
Applying biopharmaceutical classification system (BCS) criteria to predict oral absorption of drugs in dogs: challenges and pitfalls
MG Papich, MN Martinez
The AAPS journal 17, 948-964, 2015
1332015
Pharmacogenetic and metabolic differences between dog breeds: their impact on canine medicine and the use of the dog as a preclinical animal model
S Fleischer, M Sharkey, K Mealey, EA Ostrander, M Martinez
The AAPS journal 10, 110-119, 2008
1252008
Applying the biopharmaceutics classification system to veterinary pharmaceutical products: Part II. Physiological considerations
M Martinez, G Amidon, L Clarke, WW Jones, A Mitra, J Riviere
Advanced drug delivery reviews 54 (6), 825-850, 2002
1252002
In vitro and in vivo considerations associated with parenteral sustained release products: a review based upon information presented and points expressed at the 2007 Controlled …
M Martinez, M Rathbone, D Burgess, M Huynh
Journal of Controlled Release 129 (2), 79-87, 2008
1202008
The pharmacogenomics of P‐glycoprotein and its role in veterinary medicine
M Martinez, S Modric, M Sharkey, L Troutman, L Walker, K Mealey
Journal of veterinary pharmacology and therapeutics 31 (4), 285-300, 2008
992008
AUC/MIC: a PK/PD index for antibiotics with a time dimension or simply a dimensionless scoring factor?
PL Toutain, A Bousquet-Melou, M Martinez
Journal of Antimicrobial Chemotherapy 60 (6), 1185-1188, 2007
942007
Applying the Biopharmaceutics Classification System to veterinary pharmaceutical products: Part I: Biopharmaceutics and formulation considerations
M Martinez, L Augsburger, T Johnston, WW Jones
Advanced Drug Delivery Reviews 54 (6), 805-824, 2002
862002
Interspecies allometric scaling. Part I: prediction of clearance in large animals
I Mahmood, M Martinez, RP Hunter
Journal of veterinary pharmacology and therapeutics 29 (5), 415-423, 2006
752006
The biopharmaceutics risk assessment roadmap for optimizing clinical drug product performance
A Selen, PA Dickinson, A Müllertz, JR Crison, HB Mistry, MT Cruañes, ...
Journal of Pharmaceutical Sciences 103 (11), 3377-3397, 2014
722014
Modified release drug delivery in veterinary medicine
MJ Rathbone, MN Martinez
Drug discovery today 7 (15), 823-829, 2002
672002
Patient variation in veterinary medicine: part I. Influence of altered physiological states
M Martinez, S Modric
Journal of veterinary pharmacology and therapeutics 33 (3), 213-226, 2010
642010
What does it “mean”? A review of interpreting and calculating different types of means and standard deviations
MN Martinez, MJ Bartholomew
Pharmaceutics 9 (2), 14, 2017
632017
Mathematical modeling and simulation in animal health. Part III: Using nonlinear mixed‐effects to characterize and quantify variability in drug pharmacokinetics
C Bon, PL Toutain, D Concordet, R Gehring, T Martin‐Jimenez, J Smith, ...
Journal of veterinary pharmacology and therapeutics 41 (2), 171-183, 2018
602018
Factors influencing the gastric residence of dosage forms in dogs
MN Martinez, MG Papich
Journal of pharmaceutical sciences 98 (3), 844-860, 2009
582009
Factors influencing the use and interpretation of animal models in the development of parenteral drug delivery systems
MN Martinez
The AAPS journal 13 (4), 632-649, 2011
562011
Breakout session summary from AAPS/CRS joint workshop on critical variables in the in vitro and in vivo performance of parenteral sustained release products
MN Martinez, MJ Rathbone, D Burgess, M Huynh
Journal of Controlled Release 142 (1), 2-7, 2010
562010
Challenges in exploring the cytochrome P450 system as a source of variation in canine drug pharmacokinetics
MN Martinez, L Antonovic, M Court, M Dacasto, J Fink-Gremmels, ...
Drug metabolism reviews 45 (2), 218-230, 2013
532013
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20